Compounds > lidocaine

lidocaine and u-50488

lidocaine has been researched along with u-50488 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldin, AL; Pugsley, MK; Yu, EJ1
Gebhart, GF; Joshi, SK1

Other Studies

2 other study(ies) available for lidocaine and u-50488

ArticleYear
U-50,488H, a kappa opioid receptor agonist, is a more potent blocker of cardiac sodium channels than lidocaine.
    Proceedings of the Western Pharmacology Society, 2000, Volume: 43

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Anti-Arrhythmia Agents; DNA; Electrophysiology; Heart; Lidocaine; Myocardium; Oocytes; Patch-Clamp Techniques; Rats; Receptors, Opioid, kappa; Sodium Channel Blockers; Xenopus laevis

2000
Nonopioid actions of U50,488 enantiomers contribute to their peripheral cutaneous antinociceptive effects.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Anesthetics, Local; Animals; Drug Interactions; Lidocaine; Male; Molecular Conformation; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Sodium Channel Blockers; Stereoisomerism

2003